aTyr Pharma Inc.

NASDAQ: LIFE · Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM

aTyr Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
10.36M 11.05M 11.46M 6.8M 6.81M 22.54M 9.79M 12.31M 20.69M 9.98M 18.36M 8.48M 8.32M 2.34M 59.74M 2.19M 12.59M
Short-Term Investments
n/a n/a n/a n/a 77.69M 75.62M 92.34M 96.27M 93.69M 56.16M 59.02M 80.07M 90.34M 105.58M 56.61M 41.87M 38.05M
Long-Term Investments
n/a n/a n/a n/a 3.21M 3.48M 3.45M 3.42M 3.19M 3.17M 2.24M 733K n/a n/a n/a n/a n/a
Other Long-Term Assets
2.5M 3.02M 3.06M 3.03M 3.34M 131K -298K 72K 144K -22K -2.24M 175K 176K n/a n/a 152K n/a
Receivables
988K 1.74M 1.83M 1.63M 2.48M 2.44M 2.09M 1.29M 1.63M 11.78M 873K 426K 426K 435K 129K 90K 89K
Inventory
n/a n/a n/a n/a n/a n/a -95.42M -96.27M -95.32M -2.95M 169K n/a n/a n/a n/a n/a n/a
Other Current Assets
71.92M 69.16M 63.03M 81.86M 9.94M 2.39M 95.42M 100.83M 98.76M 2.95M 6.39M 4.38M 4.03M 5.38M 5.25M 2.26M 1.64M
Total Current Assets
83.27M 81.95M 76.32M 90.3M 96.92M 102.99M 107.67M 114.43M 119.45M 81.09M 87.04M 93.36M 103.12M 113.73M 121.73M 46.41M 52.37M
Property-Plant & Equipment
11.48M 11.86M 12.24M 12.62M 12.99M 14.05M 14.25M 14.82M 14.06M 11.56M 9.01M 1.75M 1.48M 1.81M 2.19M 2.44M 2.76M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
13.97M 14.88M 15.3M 15.64M 16.34M 19.07M 17.4M 18.32M 17.39M 14.7M 9.01M 2.66M 1.66M 1.81M 2.19M 2.59M 2.76M
Total Assets
97.25M 96.83M 91.62M 105.94M 113.25M 122.07M 125.07M 132.75M 136.84M 95.79M 96.06M 96.02M 104.78M 115.54M 123.92M 48.99M 55.13M
Account Payables
1.53M 4.32M 3.95M 1.25M 4.89M 3.53M 2.04M 516K 3.96M 3.11M 3.13M 1.67M 1.56M 1.03M 900K 2.22M 1.16M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
1.29M 1.25M 1.21M 1.17M 1.14M 1.33M 1.23M 1.06M 801K 894K 815K 976K 1.01M 980K 949K 919K 890K
Other Current Liabilities
7.86M 9.39M 8.96M 9.41M 9.95M 11.56M 9.61M 10.79M 8.89M 9.86M 7.27M 6.61M 3.69M 4M 3.97M 4.14M 2.4M
Total Current Liabilities
10.68M 14.97M 14.12M 11.84M 15.98M 16.42M 12.88M 12.37M 13.65M 13.86M 11.21M 9.26M 6.27M 6.01M 5.82M 7.28M 4.45M
Long-Term Debt
11.7M 12.03M 12.36M 12.68M 12.99M 13.77M 13.98M 14.33M 13.49M 10.64M 7.84M 298K 133K 398K 657K 906K 1.15M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a -1.41M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
11.7M 12.03M 12.36M 12.68M 12.99M 15.18M 13.98M 14.33M 13.49M 10.64M 7.84M 298K 133K 398K 657K 906K 1.15M
Total Liabilities
22.2M 26.81M 26.29M 24.33M 28.97M 31.6M 26.87M 26.7M 27.14M 24.5M 19.05M 9.56M 6.4M 6.41M 6.48M 8.19M 5.6M
Total Debt
12.99M 13.28M 13.57M 13.85M 14.13M 15.1M 15.22M 15.39M 14.29M 11.53M 8.65M 1.27M 1.15M 1.38M 1.61M 1.82M 2.04M
Common Stock
89K 84K 76K 76K 68K 63K 59K 57K 53K 29K 29K 28K 28K 28K 28K 16K 16K
Retained Earnings
-546.93M -532.05M -517.08M -499.82M -483.51M -468.02M -453.26M -441.92M -429.58M -417.63M -410.11M -396.87M -384.45M -372.3M -363.74M -356.07M -345.68M
Comprehensive Income
-66K -40K 36K -168K -158K -74K -294K -333K -248K -433K -669K -810K -759K -263K -69K -61K -57K
Shareholders Equity
75.05M 70.02M 65.33M 81.61M 84.47M 90.66M 98.2M 106.24M 109.88M 71.28M 77.01M 86.64M 98.55M 109.13M 117.44M 40.98M 49.53M
Total Investments
n/a n/a n/a n/a 80.9M 79.11M 92.34M 96.27M 93.69M 56.16M 59.02M 80.07M 90.34M 105.58M 56.61M 41.87M 38.05M